In Vitro Susceptibility of Mycobacterium tuberculosis to Amikacin, Kanamycin, and Capreomycin

Amikacin Optimal Exposure Targets in the Hollow-Fiber System Model of Tuberculosis

(2016) Shashikant Srivastava et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in China

(2016) Xubin Zheng et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Immunoassay Analysis of Kanamycin in Serum Using the Tobramycin Kit

(2016) J. A. Dijkstra et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Current status and opportunities for therapeutic drug monitoring in the treatment of tuberculosis

(2016) Marlanka A. Zuur et al.   Expert Opinion on Drug Metabolism & Toxicology

Sensititre MycoTB Plate Compared to Bactec MGIT 960 for First- and Second-Line Antituberculosis Drug Susceptibility Testing in Tanzania: a Call To Operationalize MICs

(2015) Scott K. Heysell et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Limited sampling strategies for therapeutic drug monitoring of amikacin and kanamycin in patients with multidrug-resistant tuberculosis

(2015) J.A. Dijkstra et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Genotypic Susceptibility Testing of Mycobacterium tuberculosis Isolates for Amikacin and Kanamycin Resistance by Use of a Rapid Sloppy Molecular Beacon-Based Assay Identifies More Cases of Low-Level Drug Resistance than Phenotypic Lowenstein-Jensen Testing

(2014) Soumitesh Chakravorty et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Quantification of amikacin and kanamycin in serum using a simple and validated LC–MS/MS method

(2014) Jacob A Dijkstra et al.   Bioanalysis

Comparison between the BACTEC MGIT 960 system and the agar proportion method for susceptibility testing of multidrug resistant tuberculosis strains in a high burden setting of South Africa

(2012) Halima M Said et al.   BMC INFECTIOUS DISEASES

Evaluation of Genetic Mutations Associated with Mycobacterium tuberculosis Resistance to Amikacin, Kanamycin and Capreomycin: A Systematic Review

(2012) Sophia B. Georghiou et al.   PLoS One

Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis

(2011) A. Engstrom et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Wild-Type MIC Distributions for Aminoglycoside and Cyclic Polypeptide Antibiotics Used for Treatment of Mycobacterium tuberculosis Infections

(2010) P. Jureen et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis

(2009) M. A. Zaunbrecher et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA